SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-047109
Filing Date
2019-02-21
Accepted
2019-02-21 16:53:03
Documents
9
Period of Report
2019-02-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d714860d8k.htm 8-K 26986
2 EX-1.1 d714860dex11.htm EX-1.1 207817
3 EX-1.2 d714860dex12.htm EX-1.2 202816
4 EX-3.1 d714860dex31.htm EX-3.1 74718
5 EX-4.1 d714860dex41.htm EX-4.1 6694
6 EX-5.1 d714860dex51.htm EX-5.1 10419
7 EX-99.1 d714860dex991.htm EX-99.1 9794
8 GRAPHIC g714860g0221012029503.jpg GRAPHIC 2522
9 GRAPHIC g714860g0221012341042.jpg GRAPHIC 6305
  Complete submission text file 0001193125-19-047109.txt   552915
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 19622578
SIC: 2834 Pharmaceutical Preparations